Swedish Project Will Sequence Tumor Exomes to Study Drug Resistance, Develop Companion Tests | GenomeWeb

By Monica Heger

This story was originally published on Aug. 30.

Researchers at Sweden's Uppsala University plan to sequence the exomes of 100 cancer patients before and after treatment to find biomarkers that predict drug responsiveness with the aim of eventually developing companion diagnostic tests.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.